Spirosure
Pleasanton
About Spirosure
Spirosure develops breath-analysis devices to apply novel breath-based analysis in disease diagnosis and management. Their breath-analysis devices focus on providing non-invasive products for the management of chronic diseases including asthma, COPD, and chronic pulmonary hypertension using a nexus of consumer technologies for preventative healthcare through sensors and algorithms. They enable medical researchers to detect biomarkers in a patient's breath to diagnose and monitor respiratory conditions.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $41.0M
- Funding stage: M&A
- Last round: Series C (Jan 2018)
- Website: spirosure.com
- Phone: +1 925 388 6370
Industries & Categories
Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/spirosure-38381 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.